2024 MSK Cardio-Oncology Symposium — On Demand (Videos + PDFs)

Advanced Cardio-Oncology Education for Cardiologists, Oncologists, and Cancer Care Specialists

The 2024 MSK Cardio-Oncology Symposium — On Demand is a comprehensive educational program from Memorial Sloan Kettering Cancer Center that provides cutting-edge training in the prevention, diagnosis, monitoring, and management of cardiovascular disease in cancer patients and survivors. Featuring leading experts from MSK and internationally recognized institutions, this symposium delivers a state-of-the-art, case-based curriculum covering the rapidly evolving field of cardio-oncology.

As cancer survival continues to improve, cardiovascular disease has emerged as a major cause of morbidity and mortality among cancer survivors. This program addresses the growing need for clinicians to understand the cardiovascular effects of modern cancer therapies and develop strategies to optimize both cancer outcomes and cardiovascular health.

Format: On-Demand Videos + Educational Resources
Conference Date: May 2–3, 2024
Specialty: Cardio-Oncology | Cardiology | Oncology

Course Overview

Modern cancer therapies have transformed oncology, dramatically improving patient survival. However, many of these treatments carry significant cardiovascular risks, including heart failure, myocarditis, arrhythmias, hypertension, vascular disease, and thromboembolic complications.

The 2024 MSK Cardio-Oncology Symposium provides a multidisciplinary review of these challenges and offers practical guidance on balancing optimal cancer treatment with cardiovascular safety. Through expert lectures, clinical case discussions, and evidence-based recommendations, participants gain valuable insights into contemporary cardio-oncology practice.

Target Audience

This course is designed for:

Physicians

• Cardiologists

• Cardio-Oncology Specialists

• Hematologists

• Medical Oncologists

• Radiation Oncologists

• Internal Medicine Physicians

• Family Medicine Physicians

• Critical Care Physicians

• Emergency Medicine Physicians

• Geriatric Medicine Physicians

• Hospice and Palliative Care Physicians

Cancer Specialists

• Bone Marrow Transplant Specialists

• Cellular Therapy Specialists

• Leukemia Specialists

• Lymphoma Specialists

• Solid Tumor Oncologists

Advanced Practice Providers

• Nurse Practitioners

• Physician Assistants

Healthcare Professionals

• Oncology Nurses

• Cardiology Nurses

• Fellows and Residents

Learning Objectives

Upon completion of this activity, participants should be able to:

• Describe cardiovascular toxicities associated with modern cancer therapies

• Develop monitoring strategies for cardiotoxicity prevention and detection

• Apply evidence-based approaches to managing treatment-related cardiovascular complications

• Utilize advanced cardiovascular imaging in cardio-oncology practice

• Diagnose and manage cardiac amyloidosis

• Implement permissive cardiotoxicity strategies when appropriate

• Identify late cardiovascular effects of cancer therapy

• Manage acute cardiovascular emergencies in patients undergoing cancer treatment

Contemporary Cancer Therapies and Cardiotoxicity

Anthracycline Cardiotoxicity

Topics Covered

• Mechanisms of Cardiac Injury

• Risk Assessment

• Surveillance Strategies

• Prevention and Treatment

Targeted Cancer Therapies

Areas Covered

• HER2-Directed Therapies

• Tyrosine Kinase Inhibitors

• VEGF Inhibitors

• Novel Targeted Agents

Immunotherapy and Cellular Therapy

Topics Include

• Immune Checkpoint Inhibitors

• CAR-T Cell Therapy

• Myocarditis

• Cytokine Release Syndrome

• Cardiovascular Monitoring

Radiation-Induced Cardiovascular Disease

Topics Covered

• Coronary Artery Disease

• Valvular Heart Disease

• Pericardial Disease

• Long-Term Surveillance

Monitoring and Management of Cardiotoxicity

Cardiovascular Surveillance

Topics Include

• Baseline Risk Assessment

• Biomarker Monitoring

• Echocardiographic Surveillance

• Longitudinal Follow-Up

Evidence and Knowledge Gaps

Areas Covered

• Current Guidelines

• Emerging Research

• Areas Requiring Further Investigation

Permissive Cardiotoxicity

Balancing Cancer Therapy and Cardiovascular Risk

Topics Covered

• Risk-Benefit Analysis

• Continuation of Life-Saving Cancer Therapy

• Individualized Decision-Making

• Multidisciplinary Care Models

Cardiac Amyloidosis

Advances in Diagnosis and Treatment

Topics Include

• ATTR Amyloidosis

• AL Amyloidosis

• Imaging Techniques

• Biomarker Evaluation

• Novel Therapeutic Approaches

Cardiovascular Imaging in Cardio-Oncology

Modern Imaging Modalities

Topics Covered

• Echocardiography

• Global Longitudinal Strain (GLS)

• Cardiac MRI

• Cardiac CT

• Nuclear Cardiology

Best Practice Applications

Areas Covered

• Imaging Guidelines

• Monitoring Protocols

• Early Detection of Cardiotoxicity

Cancer Survivorship and Cardiovascular Health

Long-Term Cardiovascular Sequelae

Topics Include

• Heart Failure

• Coronary Artery Disease

• Arrhythmias

• Valvular Disease

• Vascular Disease

Survivors of Childhood Cancer

Areas Covered

• Long-Term Monitoring

• Cardiovascular Risk Assessment

• Survivorship Care Plans

Acute Cardiovascular Disease During Cancer Treatment

Cardio-Oncology Emergencies

Topics Covered

• Acute Heart Failure

• Myocarditis

• Arrhythmias

• Acute Coronary Syndromes

• Thromboembolic Disease

Critical Care Considerations

Areas Covered

• Hemodynamic Support

• Intensive Care Management

• Multidisciplinary Coordination

Case-Based Learning

Participants review:

• Anthracycline-Induced Cardiomyopathy

• Immunotherapy-Associated Myocarditis

• Cardiac Amyloidosis Cases

• Cancer Survivor Cardiovascular Screening

• Acute Cardio-Oncology Emergencies

• Advanced Imaging Interpretation

• Complex Clinical Management Scenarios

Educational Highlights

Memorial Sloan Kettering Faculty

Learn from internationally recognized leaders in cardio-oncology and cancer survivorship.

Comprehensive Curriculum

Covers cardiovascular care throughout the entire cancer treatment continuum.

Multidisciplinary Approach

Integrates cardiology, oncology, hematology, imaging, transplantation, and critical care perspectives.

Practical Clinical Application

Provides evidence-based strategies that can be immediately applied to patient care.

Why This Course Stands Out

✔ Comprehensive Cardio-Oncology Training

✔ Modern Cancer Therapy Cardiotoxicity Review

✔ Advanced Cardiac Imaging Applications

✔ Cardiac Amyloidosis Updates

✔ Immunotherapy and CAR-T Cardiovascular Complications

✔ Permissive Cardiotoxicity Strategies

✔ Cancer Survivorship Cardiovascular Care

✔ Acute Cardio-Oncology Emergency Management

✔ Evidence-Based Monitoring Protocols

✔ Expert International Faculty

✔ Case-Based Learning

✔ State-of-the-Art Clinical Updates

Who Should Take This Course?

Ideal for:

• Cardiologists

• Cardio-Oncology Specialists

• Medical Oncologists

• Hematologists

• Radiation Oncologists

• Internal Medicine Physicians

• Advanced Practice Providers

• Oncology Nurses

• Cardiology Fellows

• Oncology Fellows

Clinical & Educational Value

The 2024 MSK Cardio-Oncology Symposium — On Demand offers a comprehensive review of cardiovascular disease in cancer patients and survivors, focusing on prevention, surveillance, diagnosis, and management of treatment-related cardiovascular complications. This program equips healthcare professionals with the latest evidence-based strategies to improve both cardiovascular and oncologic outcomes in an increasingly complex patient population.